Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, April 19, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 first quarter financial results after the market closes on Thursday, May 3, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Thursday, May 3, 2018, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 9299518. To listen to the live...Read More
SAN FRANCISCO, March 15, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) (“Invuity” or the “Company”), a leading medical technology company focused on minimal access surgery, today announced the pricing of its public offering of 6,200,000 shares of its common stock at a price to the public of $3.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of its common stock. William Blair & Company, L.L.C. is acting as the sole book-running manager for the offering. The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-212395) that was initially filed with the U.S...Read More
SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Invuity expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. Invuity intends to use the net proceeds from the offering for continued expansion of its sales and marketing activities, working capital and other general corporate purposes. William Blair & Company, L.L.C. is acting as the sole book-running manager...Read More
“The light improves my visualization in the surgical field, allowing me to be more precise with my bone cuts and joint preparation”
“This is revolutionary technology that will change the way we do minimally invasive breast surgery. It is simply must have instrumentation to work more confident, and efficient in delicate anatomy.”
Anne Arundel Medical Center
“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
New York, NY